0001819718-26-000013.txt : 20260902
0001819718-26-000013.hdr.sgml : 20260902
20260902204233
ACCESSION NUMBER: 0001819718-26-000013
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20260902
DATE AS OF CHANGE: 20260902
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulgent Genetics, Inc.
CENTRAL INDEX KEY: 0001674930
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
EIN: 812621304
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-37894
FILM NUMBER: 261356460
BUSINESS ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
BUSINESS PHONE: 626-350-0537
MAIL ADDRESS:
STREET 1: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
FORMER COMPANY:
FORMER CONFORMED NAME: Fulgent Diagnostics, Inc.
DATE OF NAME CHANGE: 20160517
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xie Jian
CENTRAL INDEX KEY: 0001819718
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O FULGENT GENETICS, INC.
STREET 2: 4399 SANTA ANITA AVE
CITY: EL MONTE
STATE: CA
ZIP: 91731
144
1
primary_doc.xml
144
0001819718
XXXXXXXX
LIVE
0001674930
FULGENT GENETICS, INC.
001-37894
4399 Santa Anita Ave
El Monte
CA
91731
626-350-0537
Xie Jian
Officer
Common Stock
Morgan Stanley Smith Barney LLC
1 New York Plaza, 38th FL
New York
NY
10004
2127
41809.21
27515293
09/02/2026
NASDAQ
Common Stock
02/25/2025
Resticted stock vest
Fulgent Genetics, Inc.
N
45304
02/25/2025
Equity compensation for services rendered
N
Jian Xie
C/O Fulgent Genetics, Inc.
4399 Santa Anita Avenue
El Monte
CA
91731
Common Stock
06/02/2026
2146
38382.27
Jian Xie
C/O Fulgent Genetics, Inc.
4399 Santa Anita Avenue
El Monte
CA
91731
Common Stock
08/27/2026
1193
23746.99
Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale, along with sales during the past 3 months, were made to satisfy tax withholding obligations through "sell to cover" transactions and do not represent a discretionary trade by the reporting person.
09/02/2026
/s/ Paul Kim as Attorney-in-Fact